Evidence map›Paper›PMID 31028139›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2019

Hit and run versus long-term activation of PARP-1 by its different domains fine-tunes nuclear processes.

Colin Thomas, Yingbiao Ji, Chao Wu, Haily Datz, Cody Boyle, Brett MacLeod, Shri Patel, Michelle Ampofo, Michelle Currie, Jonathan Harbin and 4 more

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 96 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Disordered Protein Tail Is Wagging Poly(ADP-ribosyl)ation.International journal of molecular sciences · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. PARG Protein Regulation Roles inInternational journal of molecular sciences · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. PARP1 modulates METTL3 promoter chromatin accessibility and associated LPAR5 RNA mMolecular therapy : the journal of the American Society of Gene Therapy · 2023
    Article
  18. Current issues in molecular biology · 2023
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Colin ThomasThomas Jefferson University Hospital, Philadelphia, PA 19107.
Yingbiao JiFox Chase Cancer Center, Philadelphia, PA 19111.
Chao WuFox Chase Cancer Center, Philadelphia, PA 19111.
Haily DatzDepartment of Biomedical Sciences, University of North Dakota, Grand Forks, ND 58201.
Cody BoyleDepartment of Biomedical Sciences, University of North Dakota, Grand Forks, ND 58201.
Brett MacLeodDepartment of Biomedical Sciences, University of North Dakota, Grand Forks, ND 58201.
Shri PatelDepartment of Biomedical Sciences, University of North Dakota, Grand Forks, ND 58201.
Michelle AmpofoFox Chase Cancer Center, Philadelphia, PA 19111.
Michelle CurrieRowan University, Glassboro, NJ 08028.
Jonathan HarbinRowan University, Glassboro, NJ 08028.
Kate PechenkinaQueens College, CUNY, Queens, NY 11367.ORCID 0000-0001-8117-2442
Niraj LodhiFox Chase Cancer Center, Philadelphia, PA 19111.
Sarah J JohnsonDepartment of Biomedical Sciences, University of North Dakota, Grand Forks, ND 58201.
Alexei V TulinDepartment of Biomedical Sciences, University of North Dakota, Grand Forks, ND 58201; alexei.tulin@und.edu.
University of North Dakota · USFox Chase Cancer Center · USRowan University · USQueens College, CUNY · USThomas Jefferson University Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Poly(ADP-ribose) polymerase 1 (PARP-1) is a multidomain multifunctional nuclear enzyme involved in the regulation of the chromatin structure and transcription. PARP-1 consists of three functional domains: the N-terminal DNA-binding domain (DBD) containing three zinc fingers, the automodification domain (A), and the C-terminal domain, which includes the protein interacting WGR domain (W) and the catalytic (Cat) subdomain responsible for the poly(ADP ribosyl)ating reaction. The mechanisms coordinating the functions of these domains and determining the positioning of PARP-1 in chromatin remain unknown. Using multiple deletional isoforms of PARP-1, lacking one or another of its three domains, as well as consisting of only one of those domains, we demonstrate that different functions of PARP-1 are coordinated by interactions among these domains and their targets. Interaction between the DBD and damaged DNA leads to a short-term binding and activation of PARP-1. This "hit and run" activation of PARP-1 initiates the DNA repair pathway at a specific point. The long-term chromatin loosening required to sustain transcription takes place when the C-terminal domain of PARP-1 binds to chromatin by interacting with histone H4 in the nucleosome. This long-term activation of PARP-1 results in a continuous accumulation of pADPr, which maintains chromatin in the loosened state around a certain locus so that the transcription machinery has continuous access to DNA. Cooperation between the DBD and C-terminal domain occurs in response to heat shock (HS), allowing PARP-1 to scan chromatin for specific binding sites.

Indexed as

AnimalsChromatinDrosophilaEnzyme ActivationHistonesPoly (ADP-Ribose) Polymerase-1Protein DomainsTranscriptional ActivationChromatinHistonesPoly (ADP-Ribose) Polymerase-1drosophilaPARP-1PARP-1 regulationpoly(ADP-ribose)protein domains

Identifiers

PMID31028139
PMCPMC6525528
OpenAlexW2941592428

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.